tiprankstipranks
Proteome Sciences (GB:PRM)
:PRM

Proteome Sciences (PRM) Price & Analysis

Compare
2 Followers

PRM Stock Chart & Stats


---

Financials

Quarterly

PRM FAQ

What was Proteome Sciences’s price range in the past 12 months?
Proteome Sciences lowest share price was 2.22p and its highest was 5.40p in the past 12 months.
    What is Proteome Sciences’s market cap?
    Proteome Sciences’s market cap is £11.98M.
      When is Proteome Sciences’s upcoming earnings report date?
      Proteome Sciences’s upcoming earnings report date is Apr 08, 2025 which is in 6 days.
        How were Proteome Sciences’s earnings last quarter?
        Currently, no data Available
        Is Proteome Sciences overvalued?
        According to Wall Street analysts Proteome Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Proteome Sciences pay dividends?
          Proteome Sciences does not currently pay dividends.
          What is Proteome Sciences’s EPS estimate?
          Proteome Sciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Proteome Sciences have?
          Proteome Sciences has 295,182,040 shares outstanding.
            What happened to Proteome Sciences’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Proteome Sciences?
            Currently, no hedge funds are holding shares in GB:PRM
            ---

            Company Description

            Proteome Sciences

            Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Bioventix
            Genedrive
            N4 Pharma
            Oxford BioMedica
            Abingdon Health PLC
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis